Fund shareholders of Grace Therapeutics Inc
ISIN US00439U1043 · United States · LEI 529900NF00G2BB523B88
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 2M $
- Share of capital
- 2.6 % of 16.3M shares on Jun 15, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 400,350 | 1.9M $ | 0.00 % | 2.46 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 15,895 | 73.6K $ | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 5,571 | 23.9K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 1,306 | 6K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| TIFF MULTI-ASSET FUND TIFF Investment Program | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | +1 | 423,122 | +0.6 % |
| 2026Q1 | 3 | +1 | 420,802 | +3.7 % |
| 2025Q4 | 2 | 0 | 405,921 | -2.1 % |
| 2025Q3 | 2 | 0 | 414,671 | +58.5 % |
| 2025Q2 | 2 | 0 | 261,667 | +14.7 % |
| 2025Q1 | 2 | 228,058 |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Cerity Partners LLC | 849,055 | 3.9M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 756,600 | 3.5M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 728,203 | 3.4M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 494,723 | 2.3M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 243,910 | 1.1M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 167,097 | 773.7K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 98,742 | 457.2K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 91,416 | 423.3K $ | as of Mar 31, 2026 |
| Connective Capital Management, LLC | 84,549 | 391.5K $ | as of Mar 31, 2026 |
| Quadrature Capital Ltd | 66,822 | 309.4K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 63,094 | 292.1K $ | as of Mar 31, 2026 |
| Birchview Capital, LP | 50,000 | 231.5K $ | as of Mar 31, 2026 |
| Diametric Capital, LP | 39,796 | 184.3K $ | as of Mar 31, 2026 |
| Pale Fire Capital SE | 37,762 | 174.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 26,301 | 121.8K $ | as of Mar 31, 2026 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 13,000 | 60.2K $ | as of Mar 31, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,074 | 46.6K $ | as of Mar 31, 2026 |
| OPPENHEIMER & CO INC | 10,000 | 46.3K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 7,100 | 32.9K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 5,000 | 23.2K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 4,548 | 21.1K $ | as of Mar 31, 2026 |
| NATIONAL BANK OF CANADA /FI/ | 2,716 | 12.6K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 1,800 | 8.3K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 543 | 3K $ | as of Mar 31, 2026 |
| Arax Advisory Partners | 500 | 2.3K $ | as of Mar 31, 2026 |
Declared shareholders of Grace Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ADAR1 Capital Management, LLC and 2 others | 9.90 % | 1,717,426 | as of Mar 31, 2026 · SCHEDULE 13G |
| Orin Hirschman and 1 other | 4.90 % | 814,000 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Grace Therapeutics Inc". https://titelia.com/en/stocks/grace-therapeutics-inc-US00439U1043